BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36324611)

  • 1. Prognostic significance of HER2 status evaluation using immunohistochemistry in patients with urothelial carcinoma of the bladder: A retrospective single‑center experience.
    Bai X; He W; Yin H; Li X; Zhou X; Wei Z; Yu H; Gou X
    Exp Ther Med; 2022 Nov; 24(5):704. PubMed ID: 36324611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
    Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
    Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population.
    Zhou L; Shao Z; Liu Y; Yan X; Li J; Wu X; Tang B; Li S; Cui C; Chi Z; Si L; Kong Y; Mao L; Lian B; Wang X; Bai X; Dai J; Guo J; Sheng X
    Oncologist; 2023 Aug; 28(8):e617-e624. PubMed ID: 36971495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance].
    Erben P; Wezel F; Wirtz R; Martini T; Stein D; Weis CA; Hartmann A; Bolenz C
    Aktuelle Urol; 2017 Aug; 48(4):356-362. PubMed ID: 28750448
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder.
    Spradling K; Lotan Y; Shokeir A; Abol-Enein H; Mosbah A; Morgan JB; Ghoneim M; Youssef RF
    Urol Oncol; 2016 Sep; 34(9):417.e1-8. PubMed ID: 27157247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.
    Kolla SB; Seth A; Singh MK; Gupta NP; Hemal AK; Dogra PN; Kumar R
    Int Urol Nephrol; 2008; 40(2):321-7. PubMed ID: 17899426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
    Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications.
    Krüger S; Weitsch G; Büttner H; Matthiensen A; Böhmer T; Marquardt T; Sayk F; Feller AC; Böhle A
    Int J Cancer; 2002 Dec; 102(5):514-8. PubMed ID: 12432555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human epidermal growth factor receptor 2 in bladder urothelial carcinoma.
    El Ochi MR; Oukabli M; Bouaiti E; Chahdi H; Boudhas A; Allaoui M; Ameur A; Abbar M; Al Bouzidi A
    BMC Clin Pathol; 2017; 17():3. PubMed ID: 28396613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer.
    Soria F; Moschini M; Haitel A; Wirth GJ; Gust KM; Briganti A; Rouprêt M; Klatte T; Hassler MR; Karakiewicz PI; Shariat SF
    Urol Oncol; 2016 Dec; 34(12):533.e1-533.e10. PubMed ID: 27665356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladder.
    Olsson H; Fyhr IM; Hultman P; Jahnson S
    Scand J Urol Nephrol; 2012 Apr; 46(2):102-7. PubMed ID: 22150625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
    Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
    Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
    Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
    Lim S; Koh MJ; Jeong HJ; Cho NH; Choi YD; Cho do Y; Lee HY; Rha SY
    Yonsei Med J; 2016 Jul; 57(4):831-9. PubMed ID: 27189274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study.
    Nuhn P; Novara G; Seitz C; Gupta A; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Tritschler S; Martínez-Salamanca JI; Ficarra V; Karakiewicz PI; Mazzoleni G; Shariat SF; Bastian PJ
    World J Urol; 2015 Jul; 33(7):1005-13. PubMed ID: 25048439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.
    Murakami Y; Matsumoto K; Shimizu Y; Ikeda M; Amano N; Shimura S; Ishii D; Sato Y; Iwamura M
    Urol Oncol; 2021 Mar; 39(3):195.e15-195.e23. PubMed ID: 33071109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.
    Mitra AP; Skinner EC; Schuckman AK; Quinn DI; Dorff TB; Daneshmand S
    Urol Oncol; 2014 Jan; 32(1):52.e1-9. PubMed ID: 24239476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.